Skip to main content
OpenTrials
Completed

NCT Number: NCT05226416

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection

Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Anemia Arrhythmias, Cardiac Arrythmia Asthma Atrial Fibrillation Body Weight Brain Diseases Bronchial Diseases COPD Cardiomyopathies Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Chronic Disease Chronic Heart Failure Chronic Kidney Diseases Coronaviridae Infections Coronavirus Infections DVT Diabetes Mellitus Disease Attributes Embolism Embolism and Thrombosis Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Heart Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hypersensitivity Hypersensitivity, Immediate Hypertensive Heart Disease Immune System Diseases Infarction Infections Ischemia Ischemic Heart Disease Ischemic Stroke Kidney Diseases Lung Diseases Lung Diseases, Obstructive Male Urogenital Diseases Metabolic Diseases Myocardial Infarction Myocardial Ischemia Myocarditis Necrosis Neoplasms Nervous System Diseases Nidovirales Infections Nutrition Disorders Nutritional and Metabolic Diseases Obesity Oncology Overnutrition Overweight Overweight and Obesity Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Pulmonary Disease, Chronic Obstructive Pulmonary Embolism RNA Virus Infections Renal Insufficiency Renal Insufficiency, Chronic Respiratory Hypersensitivity Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Stroke Urogenital Diseases Urologic Diseases Vascular Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Eurasian Association of Therapists

Moscow, 101000, Russia

About this study

Assessment of hospital course and health status during 3, 6, 12 months after discharge in COVID-19 patients in cohorts with comorbidities and without comorbidities. Evaluation of comorbidity impact to severity of novel coronavirus disease and comorbidity impact to demand for medical care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected or confirmed COVID-19

Exclusion criteria

  • Age under 18 years.
  • Refusal to be involved in study;

Treatment and study plan

Primary outcomes

  1. death for any cause

    Time frame: From date of hospitalization until the date of first documented date of death from any cause, assessed up to 12 months

    rate of lethal outcomes

  2. hospitalization for any cause

    Time frame: 12 months after discharge

    rate of hospitalization for any cause

Secondary outcomes

  1. onset of any disease diagnosed 1 year after discharge

    Time frame: 1 year after discharge

    rate of patients with onset of any disease diagnosed 1 year after discharge

  2. rate of demand for medical care

    Time frame: 1 year after discharge

    number of patients seeking for health care after discharge

Sponsors and collaborators

Lead sponsor

Eurasian Association of Therapists

Other

Registry information

Official study title

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

Acronym: ACTIV4

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Feb 7, 2022
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.